| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf8a3231cd88b81a086ffdc933fdef2c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a5ea3215d4ccba707b78c4cf9133da5d |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D221-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-407
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2016-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f0be6cced7167edbdbfc67b0f1b349f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d8e2672cc3fc0257defb680acc22c093
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c2dce119ab275b82a4be56883b08efef
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a83f5ee937ddfcd301af3f11aa1048c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45c6a68c69d89b331f68c525217cb5fb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca4db65a6e7147bc72899c158ec5a02b |
| publicationDate |
2018-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3321264-A1 |
| titleOfInvention |
Selective inhibitors of genotoxic stress-induced ikk/nf-kb pathways |
| abstract |
The invention relates to chemical compounds and their use as a medicament in the treatment of a disease associated with genotoxic stress-induced IKK/NF-κB (NF-kappaB) activation. The invention further relates to a pharmaceutical composition comprising a compound of the invention for the treatment of a subject afflicted by a disease associated with genotoxic stress-induced IKK/NF-κB activation. |
| priorityDate |
2016-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |